01:36 PM EST, 02/26/2025 (MT Newswires) -- AIM ImmunoTech ( AIM ) said Wednesday that NYSE American accepted the company's plan to regain compliance with the stock exchange's minimum stockholders' equity requirements.
The company said it has until June 11, 2026, to regain compliance.
Shares of AIM ImmunoTech ( AIM ) were up 3.9% in recent trading.